Literature DB >> 2841549

Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives.

J Pitha1, T Irie, P B Sklar, J S Nye.   

Abstract

Conversion of crystalline alpha-, beta-, or gamma-cyclodextrins into amorphous mixtures of water soluble derivatives yields non-toxic solubilizers which dissolve drugs through the formation of inclusion complexes. From these types of compounds 2-hydroxypropyl ethers of cyclodextrins have presently been investigated and the ranges for the safe use in working with (a) receptor binding assays on membrane preparations, (b) cells in vitro, and (c) parenteral use in mice were established for these compounds. The drugs which were investigated were dissolved in amounts linearly proportionate to the concentration of the solubilizers used and did not precipitate upon dilution by aqueous media. These solubilizers may considerably facilitate pharmacological evaluation of new, water insoluble potential drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841549     DOI: 10.1016/0024-3205(88)90150-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  55 in total

1.  Plasma membrane cholesterol modulates cellular vacuolation induced by the Helicobacter pylori vacuolating cytotoxin.

Authors:  Hetal K Patel; David C Willhite; Rakhi M Patel; Dan Ye; Christopher L Williams; Eric M Torres; Kent B Marty; Robert A MacDonald; Steven R Blanke
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.

Authors:  Joanna Rejman; Volker Oberle; Inge S Zuhorn; Dick Hoekstra
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

3.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

4.  Cellular binding, motion, and internalization of synthetic gene delivery polymers.

Authors:  Gaelen T Hess; William H Humphries; Nicole C Fay; Christine K Payne
Journal:  Biochim Biophys Acta       Date:  2007-08-07

5.  Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.

Authors:  V M Atger; M de la Llera Moya; G W Stoudt; W V Rodrigueza; M C Phillips; G H Rothblat
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

6.  2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease.

Authors:  Sarah Ward; Patricia O'Donnell; Steven Fernandez; Charles H Vite
Journal:  Pediatr Res       Date:  2010-07       Impact factor: 3.756

7.  Application of 2-hydroxypropyl-beta-cyclodextrin in the assay of acyl-CoA:cholesterol acyltransferase and neutral and acid cholesterol ester hydrolases.

Authors:  M Liza; J R Romero; Y Chico; O Fresnedo; B Ochoa
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

8.  Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization.

Authors:  Mireille Guyader; Etsuko Kiyokawa; Laurence Abrami; Priscilla Turelli; Didier Trono
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Effects of inclusion complexation on the transepithelial transport of a lipophilic substance in vitro.

Authors:  M J Cho; F J Chen; D L Huczek
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

10.  Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.

Authors:  H Arima; H Adachi; T Irie; K Uekama; J Pitha
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.